Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Triheptanoin in adults with McArdle disease
2014-003644-12Phase 2Completed
- Sponsor
- Neuromuscular Research Unit
- Start
- Nov 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of triheptanoin in glycogen storage disease type V (GSDV), sponsored by Neuromuscular Research Unit. Primary endpoint: Exercise performance during cycle ergometry. Started Nov 2014; status: completed.
02
Drugs
triheptanoin
03
Conditions
glycogen storage disease type V (GSDV)
Beyond the preview
Go deeper on 2014-003644-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-003644-12.